ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Rancho Biosciences Expands Leadership in Biomedical Ontology With Appointment of Dr. Jane Lomax

Industry-recognized expert SciBite, and Pistoia Alliance Board Member, joins Rancho to advance structured data solutions for life sciences innovation

SAN DIEGO, CA / ACCESS Newswire / September 17, 2025 / Rancho Biosciences, most trusted partner for scientific data services for the life sciences industry, today announced the appointment of Dr. Jane Lomax as Head of Terminology Services. A globally respected leader in the field of biomedical ontology, Dr. Lomax brings decades of experience guiding ontology strategy, development, and governance for high-impact initiatives across pharma, academia, and global data consortia.

Most recently, Dr. Lomax served as Head of Ontologies for SciBite at Elsevier, where she led the development of ontology-based tools to power semantic search, data integration, and AI-ready knowledge systems. She has also served on the Board of the Pistoia Alliance and is actively involved in several of its ontology projects. She is well known for her work on landmark projects such as the Gene Ontology (GO), International Society for Biocuration, and Open Biomedical Ontologies (OBO) Foundry.

"Ontologies are the foundation for making scientific data truly interoperable and ready for discovery," said Dr. Lomax. "Joining the Rancho team feels like becoming part of a shared mission with people who believe, as I do, in saving lives through data by making it work harder, reach more people, and accelerate discovery."

Marc Ginsky, CEO of Rancho Biosciences, said: "Jane is one of the most respected leaders in the biomedical ontology field, and her track record speaks for itself. With her expertise, Rancho is even better positioned to set the standard for intelligent, interoperable and analysis- ready biomedical data-and to deliver that value at scale for our clients worldwide."

Tatiana Khasanova, SVP Science & Technology, added: "Jane's arrival strengthens the deep scientific and technical foundation that Rancho has built over more than a decade. She brings not just extraordinary knowledge of ontologies, but also a collaborative mindset that will help our clients navigate the complexities of data harmonization and knowledge modeling with confidence."

The appointment comes as Rancho continues to expand its global impact in helping pharmaceutical, biotech, and research organization's structure and harmonize their data assets-accelerating drug discovery, translational research, and AI/ML development.

Dr. Lomax will also represent Rancho at the upcoming Pistoia Alliance Conference in Q4, where the company is a featured sponsor and speaker. Her presence further reinforces Rancho's role as a thought leader in advancing FAIR data principles and domain-driven data innovation in life sciences.

About Rancho Biosciences
Rancho Biosciences is a trusted scientific data partner to the life sciences industry, helping pharmaceutical, biotech, and research organizations transform complex biomedical data into high-quality, AI-ready assets. Our expertise spans strategic data consulting, ontology development, curation, harmonization, engineering, and advanced analytics across omics, clinical, imaging, and preclinical domains.

We combine scientific insight, data mastery, and engineering excellence to deliver solutions that are precise, scalable, and built for impact. Known for speed, rigor, and the ability to make the hard things in data seem easy, Rancho serves as the backbone behind breakthroughs-empowering clients to accelerate discovery, improve decision-making, and ultimately save lives through data.

Learn more at www.ranchobiosciences.com

Contact Information

Yigal Uriel
Digital Marketing Manager
yigal.uriel@ranchobiosciences.com

.

SOURCE: Rancho BioSciences, LLC



View the original press release on ACCESS Newswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.